Please note that LIDDS will disclose information in Press releases only in English going forward. Vänligen notera att LIDDS fortsättningsvis kommer att offentliggöra pressmeddelanden endast på engelska. Erik Penser temadag med bolag i cancerforskningens frontlinje, Stockholm, October 6, 2020, Monica Wallter, CEOPress releases
LIDDS has decided to apply for listing of the company’s shares on Nasdaq Stockholm Main Market in 2021
Update on Chinese Conditional Market Approval (CMA) for Liproca® Depot
LIDDS AB (publ) announces the appointment of Nina Herne as CEO
LIDDS Delårsrapport januari – september 2020
A review article defines LIDDS as a key player in TLR9 agonist research field and being the only provider having a sustained release product in development
LIDDS publishes prospectus in connection with forthcoming rights issue
LIDDS will participate in Redeye’s Fight Cancer Seminar on March 10
Events
Company Analysis
Photo Library
News and media
We are using cookies to give you the best experience on our website.
You can find out more about which cookies we are using or switch them off in settings.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
More information about our Cookie Policy
More information about our Privacy Policy